Phase I trial of dose-escalated stereotactic radiosurgery (SRS) boost for unfavorable locally advanced oropharyngeal cancer

BACKGROUND AND PURPOSE: Patients with locally advanced oropharynx squamous cell carcinoma have suboptimal outcomes with standard chemoradiation. Here, we evaluated toxicity and oncologic outcomes of dose escalation using radiosurgical boost for patients with unfavorable oropharynx squamous cell carc...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Radiat Oncol
Autori principali: Vempati, Prashant, Halthore, Aditya N., Teckie, Sewit, Rana, Zaker, Gogineni, Emile, Antone, Jeffrey, Zhang, Honglai, Marrero, Mihaela, Beadle, Kristin, Frank, Douglas K., Aziz, Mohamed, Paul, Doru, Ghaly, Maged
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2020
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7731764/
https://ncbi.nlm.nih.gov/pubmed/33308265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-020-01718-w
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi